China Medical Technologies, Inc. (Nasdaq: CMED) today announces that it has entered into a definitive asset acquisition agreement with Molecular ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE